//@daz888888: $Lucira Health, Inc.(LHDX)$ Lucira Health, Inc. LHDX +434.6% + Free Alerts shares are surging higher on Tuesday after the company announced it submitted an Emergency Use Authorization application to the FDA for over-the-counter use of its COVID-19 & Flu test. What happened: Today, Lucira announced that it submitted an Emergency Use Authorization (EUA) application for its at-home molecular COVID-19 & Flu test kits. The company first received EUA for point-of-care use in a healthcare setting in November 2022. The company’s kits test for COVID-19 and influenza, which the company noted, have similar symptoms but different treatments that are most effective early in an
@daz888888888:Lucira Health (LHDX) Biggest Gainer ($0.13 to $0.87) 💪✅🚀